Free provider profile

MEHRDAD MAZ, MD

NPI 1720061492
Individual
Internal Medicine, Rheumatology
Active registration
Save to rep workspaceFollow this provider Sign in to find emailNPI registry

Need more providers like MEHRDAD MAZ?

See the count and top 3 free, ranked by Medicare billing. Full list $29, included with membership.

Rep intel

What MEHRDAD MAZ prescribes and who else does

Top Medicare Part D drugs by claims (public CMS data):

  • Otezla
  • Humira(Cf) Pen
  • Actemra Actpen
  • Actemra
  • Humira Pen

Your next referral list starts here

Provider + market indicator

A combined screening indicator—not a provider fraud-risk score. Local plan ratings describe the surrounding market, not this provider’s quality, plan membership or wrongdoing.

Comparing current CMS billing with peers and checking OIG and plan ratings… A new peer comparison can take about a minute.

Practice contact card

Practice phone

913-588-6009

Fax

913-588-8182

Practice address

3901 RAINBOW BLVD, KANSAS CITY, KS, 66160

Registry updated
2014-11-20
NPI issued
2005-11-27
RepVector retrieved
11/20/2026

A recent retrieval can still contain an old address if the provider has not updated their registry record. Website email checks show their own date under Find email.

Registry record

Source: CMS NPPES registry.

3901 RAINBOW BLVD, KANSAS CITY, KS, 66160

913-588-6009

Single practice location

Enumerated 2005-11-27

  • — Registration is active in NPPES.
  • — Individual clinician record — reachable, but usually not the buyer.
  • — Practice phone number is published.
  • — Full street address on file for route planning.
  • — 2 taxonomies listed — broader service mix.
  • — Record last updated 12 years ago.

Medicare Part D prescribing

Source: CMS Medicare Part D Prescribers by Provider, most recent public year.

Part D claims

1,137

Medicare patients

207

Part D drug cost

$1,470,893

Brand-name share

22.3%

of this prescriber's Part D claims

DrugClaimsMedicare cost
Humira(Cf) Pen (Adalimumab)37$243,988
Otezla (Apremilast)39$214,917
Actemra Actpen (Tocilizumab)31$140,257
Nucala (Mepolizumab)12$126,297
Humira Pen (Adalimumab)14$95,362
Taltz Autoinjector (Ixekizumab)12$81,657
Benlysta (Belimumab)13$62,662
Actemra (Tocilizumab)15$35,673

Want their full drug mix and peer benchmark? Run the free Part D prescriber lookup.

Latest Medicare Part B billing

CMS Physician and Other Practitioners, by Provider and Service. New published billing years are detected daily, using the same release as the Billing analyst and risk maps.

Loading the latest published CMS billing file…

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

Checking Open Payments…

Industry payments across KS — which companies pay providers there.

Tailored to Provider research.

Build the provider research list for one county and check the names yourself.

Name the city, county, or state. RepVector selects the datasets that matter for provider research, enriches each target with what its site publishes, and returns a scored list with phones, addresses and named contacts.

Build a provider research list

3 free runs — no card required.